# Adamantinoma and Osteofibrous Dysplasia

> Adamantinoma and osteofibrous dysplasia for NEET-PG Orthopaedics cover tibial cortex lesions, epithelial nests, cytokeratin and wide excision or observation.

- Canonical URL: https://prepelephant.com/topics/neet-pg/orthopaedics/adamantinoma-and-osteofibrous-dysplasia
- Exam / course: NEET-PG · Subject: Orthopaedics
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-15
- Last updated: 2026-10-15
- Reference basis: WHO Classification of Soft Tissue and Bone Tumours; Apley's System of Orthopaedics and Fractures; Campbell's Operative Orthopaedics
- How to cite: "Adamantinoma and Osteofibrous Dysplasia", PrepElephant, https://prepelephant.com/topics/neet-pg/orthopaedics/adamantinoma-and-osteofibrous-dysplasia

## Direct answer

Adamantinoma is a rare, low-grade malignant bone tumour that arises overwhelmingly in the anterior cortex of the tibia, and it is closely linked to osteofibrous dysplasia, a benign lesion of the same region. Adamantinoma contains epithelial nests within a fibrous stroma, which separates it from the purely fibrous osteofibrous dysplasia. Wide surgical excision is the mainstay of treatment, because inadequate surgery is the main cause of local recurrence.

## What you must remember

- **Site:** the anterior cortex of the tibial diaphysis, which is the commonest location for both lesions.
- **Age:** adamantinoma typically presents in young adults, whereas osteofibrous dysplasia is usually seen in the first decade.
- **Histology of adamantinoma:** epithelial nests and cords that stain positive for cytokeratin, set within a fibrous stroma.
- **Osteofibrous dysplasia:** a benign fibro-osseous lesion of the tibial cortex, often with woven bone, and it is considered a possible precursor of adamantinoma.
- **Radiograph:** an eccentric, multiloculated lytic lesion that can show a soap-bubble appearance, with a sclerotic rim in some cases.
- **Behaviour:** adamantinoma is locally aggressive and can metastasise to the lungs and regional nodes in a substantial minority of patients, reported at roughly 15 to 30 percent.
- **Treatment:** wide resection with a cuff of normal tissue, while chemotherapy and radiotherapy have limited roles.

## Separating two lesions with a shared fibrous background

Both lesions sit in the anterior tibia and share a fibrous background, so the diagnosis depends on finding the epithelial component. The distinction matters because the two lesions need different treatments, and getting it wrong either undertreats a malignancy or over-operates a benign lesion. The table summarises the features that matter most in practice.

| Feature | Osteofibrous dysplasia | Adamantinoma |
|---|---|---|
| Site | Anterior tibial cortex, often mid-shaft | Anterior tibial cortex, most often the diaphysis |
| Typical age | First decade of life | Young adults, often in their teens and twenties |
| Epithelial nests | Absent | Present |
| Cytokeratin | Usually negative | Positive |
| Radiograph | Sclerotic, well-defined, with a smooth outline | Multiloculated, eccentric, soap-bubble appearance |
| Behaviour | Benign, may remodel as the child grows | Malignant, locally aggressive with a slow course |
| Metastasis | None | Roughly 15 to 30 percent, mainly to lungs |
| Management | Observation, or curettage if symptomatic | Wide excision with a cuff of normal bone |

A biopsy that shows only fibrous tissue and woven bone favours osteofibrous dysplasia, whereas any epithelial nests should prompt a diagnosis of adamantinoma. Imaging and histology are read together, because the radiographic pattern overlaps, and a lesion that cannot be confidently called benign should be excised widely rather than observed.

## Where the exam tries to catch you

Most errors come from treating the two lesions as interchangeable or from choosing the wrong surgical plan.

- **Trap:** treating every tibial cortical lesion in a child as adamantinoma — **Correct:** osteofibrous dysplasia is the common benign entity in childhood and is usually managed by observation unless epithelial nests are found.
- **Trap:** curetting an adamantinoma — **Correct:** adamantinoma recurs after inadequate surgery, so wide excision is the correct approach.
- **Trap:** starting chemotherapy as first-line treatment — **Correct:** adamantinoma responds poorly to chemotherapy, so wide excision remains the mainstay.

## Frequently asked questions

### Where does adamantinoma most commonly arise?
Adamantinoma most commonly arises in the anterior cortex of the tibial diaphysis. Involvement of the fibula is uncommon. Sites outside the lower leg are rare and should prompt a careful review of the diagnosis.

### What is the relationship between adamantinoma and osteofibrous dysplasia?
Adamantinoma and osteofibrous dysplasia are closely related, and osteofibrous dysplasia is considered a possible precursor of adamantinoma. Both occur in the anterior tibial cortex, and some adamantinomas contain osteofibrous dysplasia-like areas. Recognising the epithelial nests is what separates the malignant from the benign process.

### Why does cytokeratin staining matter in adamantinoma?
Cytokeratin staining matters in adamantinoma because the epithelial nests stain positive, which confirms the epithelial component of the tumour. Osteofibrous dysplasia usually lacks this component. Cytokeratin is therefore a key marker when the two lesions must be separated on biopsy.

### What is the typical treatment for adamantinoma?
The typical treatment for adamantinoma is wide surgical excision with a cuff of normal tissue, because local recurrence follows marginal or intralesional surgery. Chemotherapy and radiotherapy have limited roles and are not first-line in most cases. Follow-up looks for local recurrence and for lung metastases, which can appear late.

### How is osteofibrous dysplasia usually managed?
Osteofibrous dysplasia is usually managed by observation, because it is benign and may remodel as the child grows. Surgical curettage or excision is reserved for symptomatic, progressive or fracture-prone lesions. Serial imaging confirms that the lesion is not evolving toward adamantinoma.
